Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | -5.26% | 0.00% | -48.57% |
05-22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
05-20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |